Is Mounjaro available in New Zealand? What we know (updated Feb 2026)

Updated February 3, 2026. People often ask a simple question (“Is Mounjaro available in NZ?”) but the real answer has three parts: regulated medicine information, public funding, and real‑world supply.

1) Medicine information (Medsafe)

New Zealand has regulated product information for Mounjaro (tirzepatide), including a data sheet and consumer medicine information (CMI). This tells clinicians and patients how the medicine is used, how dosing works, and key safety information.

2) Public funding (PHARMAC)

PHARMAC decisions are separate from medicine information. Advisory committees can consider funding applications, and PHARMAC may consult and decide later. Funding, if it happens, usually comes with eligibility criteria.

3) Real‑world access (supply + prescribing pathways)

Even if medicine information exists, a launch date, supply, and distribution determine when people can actually get it. Shortages have affected this class of medicines internationally, so supply can change quickly.

What you can do now

• Avoid buying ‘tirzepatide’ from unverified online sellers (counterfeits and scams are common).
• If you’re considering weight‑loss medication, discuss current NZ options with a clinician now rather than waiting.
• Bookmark this page. We update it when reliable public information changes.

Sources

• Medsafe data sheet: Mounjaro (tirzepatide)
• Medsafe CMI: Mounjaro
• PHARMAC: how PTAC advice fits into funding decisions
• PHARMAC: PTAC agenda mentioning tirzepatide